FDA Panel Backs New Drug for Moderate or Severe Rheumatoid Arthritis

By a 10-1 vote, a government advisory panel Tuesday backed Roche Holding AG's (RHHBY) drug Actemra...

» read full story

July 30th, 2008 - 19:10

FDA Panel Recommends New Arthritis Drug Approval

An FDA panel voted Tuesday 10 to 1 for the approval of a new drug that fights against rheumatoid...

» read full story

July 30th, 2008 - 20:09